Sumitomo Mitsui Trust Holdings, Inc. Moderna, Inc. Transaction History
Sumitomo Mitsui Trust Holdings, Inc.
- $164 Billion
- Q4 2025
A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 19,727 shares of MRNA stock, worth $488,440. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,727
Previous 15,396
28.13%
Holding current value
$488,440
Previous $397,000
22.92%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding MRNA
# of Institutions
845Shares Held
257MCall Options Held
39.6MPut Options Held
43.1M-
Vanguard Group Inc Valley Forge, PA41.2MShares$1.02 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$633 Million0.07% of portfolio
-
Baillie Gifford & CO20.6MShares$510 Million0.45% of portfolio
-
State Street Corp Boston, MA17.1MShares$424 Million0.02% of portfolio
-
Morgan Stanley New York, NY9.96MShares$247 Million0.02% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $9.69B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...